WISTA
LIVE

Serial Number

79182923

Owner

TauRx Therapeutics Ltd

Attorney

Thad Chaloemtiarana

Filing Date

Dec 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

WISTA Trademark

Serial Number: 79182923 • Registration: 5153172

WISTA is a trademark filed by TauRx Therapeutics Ltd on December 22, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TauRx Therapeutics Ltd (11 trademarks)

25 Bukit Batok Crescent,

Entity Type: 11

WisTa Laboratories Ltd (4 trademarks)

25 Bukit Batok Crescent,

Entity Type: 99

Trademark Details

Filing Date

December 22, 2015

Registration Date

March 7, 2017

Published for Opposition

December 20, 2016

Cancellation Date

September 22, 2023

Goods & Services

Pharmaceutical and medical preparations for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases

Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines, and in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugs, pharmaceuticals and medicines; scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Nov 20, 2025 CHLD
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 14, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 24, 2024 INTS
INVALIDATION PROCESSED
Jun 24, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 14, 2024 INTR
CANCELLED SECTION 71
Sep 22, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 7, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 8, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 19, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 19, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 7, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2016 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 16, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2016 CRFA
ASSIGNED TO LIE
Sep 10, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2016 TROA
REFUSAL PROCESSED BY IB
May 13, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2016 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2016 RFCR
NON-FINAL ACTION WRITTEN
Apr 14, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 27, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 22, 2016 REPR